Mucin 1, cell surface associated (MUC1) or polymorphic epithelial mucin (PEM) is a mucin encoded by the MUC1 gene in humans. MUC1 is a glycoprotein with extensive O-linked glycosylation of its extracellular domain. It is overexpressed in a variety of epithelial cancers, and plays a crucial role in progression of the disease. Tumor-associated MUC1 differs from the MUC1 expressed in normal cells with regard to its biochemical features, cellular distribution, and function. In cancer cells, MUC1 participates in intracellular signal transduction pathways and regulates the expression of its target genes at both the transcriptional and post-transcriptional levels.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | Inquiry & Datasheet |
CAR-T-1-M303-2 | Anti-MUC1 scFv h(CD28) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-CD28 | Lentiviral | T cell | |
CAR-T-1-M303-G | Anti-MUC1 scFv h(FcεRIγ) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-FcεRIγ | Lentiviral | T cell | |
CAR-T-1-M303-Z | Anti-MUC1 scFv h(CD3ζ) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-CD3ζ | Lentiviral | T cell | |
CAR-T-2-M303-2G | Anti-MUC1 scFv h(CD28-FcεRIγ) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-CD28-FcεRIγ | Lentiviral | T cell | |
CAR-T-2-M303-2Z | Anti-MUC1 scFv h(CD28-CD3ζ) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-CD28-CD3ζ | Lentiviral | T cell | |
CAR-T-2-M303-4G | Anti-MUC1 scFv h(CD4-FcεRIγ) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-CD4-FcεRIγ | Lentiviral | T cell | |
CAR-T-2-M303-4Z | Anti-MUC1 scFv h(CD4-CD3ζ) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-CD4-CD3ζ | Lentiviral | T cell | |
CAR-T-2-M303-8Z | Anti-MUC1 scFv h(CD8-CD3ζ) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-CD8-CD3ζ | Lentiviral | T cell | |
CAR-T-2-M303-BZ | Anti-MUC1 scFv h(41BB-CD3ζ) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-41BB-CD3ζ | Lentiviral | T cell | |
CAR-T-2-M303-CZ | Anti-MUC1 scFv h(b2c-CD3ζ) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-b2c-CD3ζ | Lentiviral | T cell | |
CAR-T-3-M303-2BZ | Anti-MUC1 scFv h(CD28-41BB-CD3ζ) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-CD28-41BB-CD3ζ | Lentiviral | T cell | |
CAR-T-3-M303-2XZ | Anti-MUC1 scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1 | Human | SM3; HMFG2 | Mouse | scFv-CD28-OX40-CD3ζ | Lentiviral | T cell | |
CAR-T-2-M553-BZ | Anti-MUC1 VHH h(41BB-CD3ζ) CAR, [T] | Human | camelid | VHH-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M553-CZ | Anti-MUC1 VHH h(b2c-CD3ζ) CAR, [T] | Human | camelid | VHH-b2c-CD3ζ | Lentiviral | T cell | ||
CAR-T-1-M553-2 | Anti-MUC1 VHH h(CD28) CAR, [T] | Human | camelid | VHH-CD28 | Lentiviral | T cell | ||
CAR-T-3-M553-2BZ | Anti-MUC1 VHH h(CD28-41BB-CD3ζ) CAR, [T] | Human | camelid | VHH-CD28-41BB-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M553-2Z | Anti-MUC1 VHH h(CD28-CD3ζ) CAR, [T] | Human | camelid | VHH-CD28-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M553-2G | Anti-MUC1 VHH h(CD28-FcεRIγ) CAR, [T] | Human | camelid | VHH-CD28-FcεRIγ | Lentiviral | T cell | ||
CAR-T-3-M553-2XZ | Anti-MUC1 VHH h(CD28-OX40-CD3ζ) CAR, [T] | Human | camelid | VHH-CD28-OX40-CD3ζ | Lentiviral | T cell | ||
CAR-T-1-M553-Z | Anti-MUC1 VHH h(CD3ζ) CAR, [T] | Human | camelid | VHH-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M553-4Z | Anti-MUC1 VHH h(CD4-CD3ζ) CAR, [T] | Human | camelid | VHH-CD4-CD3ζ | Lentiviral | T cell | ||
CAR-T-2-M553-4G | Anti-MUC1 VHH h(CD4-FcεRIγ) CAR, [T] | Human | camelid | VHH-CD4-FcεRIγ | Lentiviral | T cell | ||
CAR-T-2-M553-8Z | Anti-MUC1 VHH h(CD8-CD3ζ) CAR, [T] | Human | camelid | VHH-CD8-CD3ζ | Lentiviral | T cell | ||
CAR-T-1-M553-G | Anti-MUC1 VHH h(FcεRIγ) CAR, [T] | Human | camelid | VHH-FcεRIγ | Lentiviral | T cell | ||
CAR-LC251 | Anti-MUC1 h(CD28-41BB-CD3ζ) CAR, pCDCAR1 | Human | Pemtumomab | Mouse | scFv-CD28-41BB-CD3ζ | Nonviral | T cell | |
CAR-LC361 | Anti-MUC1×ERBB2 h(CD3ζ/41BB) Dual CAR, pCDCAR1 | Human | Pemtumomab | Mouse | scFv (MUC1)-CD3ζ/Herin-CD28-41BB | Nonviral | T cell | |
CAR-CQ1611 | Anti-MUC1 (CBXC-0851) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-0851 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-CQ5035 | Anti-MUC1 (CBXC-0851) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-0851 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY0609 | Anti-MUC1 (126E7) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 126E7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY0610 | Anti-MUC1 (139H2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 139H2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-WFY0611 | Anti-MUC1 (C595NCRC48) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | C595NCRC48 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |
CAR-YF251 | Anti-MUC1 (CBL-YF066) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | CBL-YF066 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
CAR-YF252 | Anti-MUC1 (CBL-YF066) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBL-YF066 | Humanized | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-ZP020 | Anti-MUC1h(CD28-CD3ζ) CAR, pCDCAR1 | Human | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP046 | Anti-MUC1h(41BB-CD3ζ) CAR, pCDCAR1 | Human | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP8854 | Anti-MUC1 (F1C-HL) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | F1C-HL | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
CAR-ZP8855 | Anti-MUC1 (M1A-HL) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | M1A-HL | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-ZP8856 | Anti-MUC1 (M1A-HL) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | M1A-HL | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
CAR-ZP8857 | Anti-MUC1 (K2B-HL) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | K2B-HL | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
CAR-ZP8858 | Anti-MUC1 (K2B-HL) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | K2B-HL | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell |
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MOREEnd-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy with the complete TCR without HLA dependence.
LEARN MORETRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MOREThe latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE